Catalyst Wire Dossier Catalyst Wire Dossier

Copegus

ribavirin · Roche
Drug timelines are a Plus or Pro feature.

91 regulatory and trial events tracked for Copegus, covering 2006-06-13 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV [Phase 2]

See pricing